InhaTarget Thereapeutics inhatarget.com


InhaTarget Therapeutics develops targeted dry powders for inhalation that aim to improve the treatment of severe and/or chronic respiratory diseases.

InhaTarget Therapeutics develops targeted dry powders for inhalation that aim to improve the treatment of severe and/or chronic respiratory diseases.

Company (Alive / Active)

Phone: +32 2 650 52 54

Fax:

Université libre de Bruxelles (ULB), Unité de Pharmacie galénique et de biopharmacie.
Campus de la Plaine CP 207, Boulevard du Triomphe
Bruxelles, 1050
Belgium

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
InhaTarget Thereapeutics $6.1M Feb 10, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related InhaTarget Thereapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)